Late thrombosis of a drug-eluting stent during combined anti-platelet therapy in a clopidogrel nonresponsive diabetic patient: shall we routinely test platelet function?
Schäfer
Andreas
A
Medizinische Klinik und Poliklinik I, Universitätsklinikum Würzburg, Josef-Schneider-Strasse 2, 97080 Würzburg, Germany. a.schaefer@medizin.uni-wuerzburg.de
Bonz
Andreas W
AW
Eigenthaler
Martin
M
Bauersachs
Johann
J
D000368:Aged; D000077144:Clopidogrel; D003328:Coronary Thrombosis / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D003331:Coronary Vessels / Q000601:surgery*; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000601:surgery*; D004351:Drug Resistance; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000601:surgery; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D010979:Platelet Function Tests; D058919:Purinergic P2 Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D015607:Stents / Q000009:adverse effects*; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives
C548576:P2RY12 protein, human; D010975:Platelet Aggregation Inhibitors; D058919:Purinergic P2 Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D000077144:Clopidogrel; D013988:Ticlopidine